TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pfizer Health AB
Closing information (x1000 SEK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
4,412,000
|
6,322,000
|
4,238,000 |
| Financial expenses |
3,000
|
0
|
1,000 |
| Earnings before taxes |
2,064,000
|
3,943,000
|
2,693,000 |
| EBITDA |
2,126,000
|
3,950,000
|
2,815,000 |
| Total assets |
8,054,000
|
11,022,000
|
9,650,000 |
| Current assets |
5,558,000
|
8,571,000
|
7,232,000 |
| Current liabilities |
1,152,000
|
1,217,000
|
803,000 |
| Equity capital |
6,653,220
|
9,599,720
|
8,638,720 |
| - share capital |
2,558,000
|
2,558,000
|
2,558,000 |
| Employees (average) |
337
|
340
|
325 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
82.6%
|
87.1%
|
89.5% |
| Turnover per employee |
13,092
|
18,594
|
13,040 |
| Profit as a percentage of turnover |
46.8%
|
62.4%
|
63.5% |
| Return on assets (ROA) |
25.7%
|
35.8%
|
27.9% |
| Current ratio |
482.5%
|
704.3%
|
900.6% |
| Return on equity (ROE) |
31.0%
|
41.1%
|
31.2% |
| Change turnover |
-1,910,000
|
2,084,000
|
1,006,000 |
| Change turnover % |
-30%
|
49%
|
31% |
| Chg. No. of employees |
-3
|
15
|
14 |
| Chg. No. of employees % |
-1%
|
5%
|
5% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.